Innovative medicines and vaccines play a vital role in improving public health, extending healthy lifespans, and strengthening national resilience. By recognizing their long-term clinical, social, and economic value, healthcare systems can better support future breakthroughs and broader patient access.
Novo Nordisk Taiwan is reframing obesity from weight loss to long-term health, emphasizing prevention, early intervention, and collaboration across Taiwan’s healthcare system. Through awareness, screening, and employee support, the company is helping advance a broader approach to metabolic health.
As Taiwan becomes a super-aged society, AmCham Taiwan 2026 Healthy Aging Forum explored how prevention, innovation, and public-private collaboration can strengthen healthcare systems and extend healthy life expectancy.
Taiwan is placing vaccination at the heart of its Healthy Taiwan agenda, treating prevention as essential to easing pressure on the healthcare system.
